Bradley Merrill Thompson Quoted in “Cures Bill Retains FDA Oversight of Software Used in Blood Transfusions”Inside CMS May 28, 2015
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Inside Health Policy’s Inside CMS, in “Cures Bill Retains FDA Oversight of Software Used in Blood Transfusions,” by Joe Williams. (Read the full version — subscription required.)
Following is an excerpt:
Bradley Thompson, an attorney at Epstein Becker & Green, previously told IHP, "We need legislation that is self-executing, that provides the software development community with clear delineation as to what's in and what's out."